Researchers at the Yale Liver Center found that patients with COVID-19 presented with abnormal liver tests at much higher rates than suggested by earlier studies. They also discovered that higher levels of liver enzymes—proteins ...
Aug 7, 2020
0
2
New guidance is available for physicians who must go through a number of steps to provide a probable diagnosis of sarcoidosis—an inflammatory disease that affects the lungs, lymph glands, and other organs. The American ...
Apr 21, 2020
0
2
For optimally engineered tissues, it is important that biological cues are delivered with appropriate timing and to specific locations. To aid in this endeavor, researchers have combined acoustic droplet ejection (ADE) technology ...
Apr 15, 2020
0
0
Acute myeloid leukemia is the most common type of leukemia in adults. It is characterized by the pathological expansion of immature cells (myeloblasts) that invade the bone marrow and expand into the blood, affecting the ...
Jan 2, 2020
0
136
A diagnostic study of 136 premature infants found that a protein involved in managing harmful bacteria in the human intestine is a reliable biomarker for the noninvasive detection of necrotizing enterocolitis (NEC). Led by ...
Nov 8, 2019
0
4
Scientists from the research group CIBERFES and the University of Granada (UGR) have implemented a protocol for effectively detecting hypophosphatasia and have discovered two new genetic mutations associated with this disease, ...
Oct 31, 2019
0
40
Serum interleukin (IL)-35 levels are associated with bone loss and may represent a novel therapeutic target for postmenopausal women with rheumatoid arthritis (RA), according to a study published online Aug. 26 in Mediators ...
Sep 27, 2019
0
4
(HealthDay)—Turalio (pexidartinib) capsules have been approved to treat adults with symptomatic tenosynovial giant cell tumor (TGCT), the U.S. Food and Drug Administration announced.
Aug 5, 2019
0
3
A research group led by Professor Hannes Lohi at the University of Helsinki and Folkhälsan Research Center has uncovered a new skeletal disease in dogs. The disease was recognized in the Karelian Bear Dog breed and associated ...
Jan 31, 2019
0
2
(HealthDay)—Denosumab (DNM), a fully human monoclonal antibody against the receptor activator of nuclear factor kappa-B ligand (RANKL), may be beneficial for managing transfusion-dependent thalassemia (TDT)-induced osteoporosis, ...
Nov 13, 2018
0
1
